IL16 and psoriasis: There were no significant statistical differences between the interleukin serum levels in patients with mild psoriasis vs. control subjects (P = 0.77), early-onset vs. late-onset psoriasis (P = 0.07) and no significant correlation between IL-16 serum levels and the quality of life assessed by DLQI (r = 0.03; P = 0.83).